| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/26/1999 | CA2320354A1 Novel compounds and their use as positive ampa receptor modulators |
| 08/26/1999 | CA2318959A1 Epimorphian compound and its use |
| 08/26/1999 | CA2318237A1 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 08/25/1999 | EP0937777A2 GABA receptors and their uses |
| 08/25/1999 | EP0937722A1 Benzimidazole derivatives as cyclooxygenase-2 inhibitors |
| 08/25/1999 | EP0937464A2 Combined pharmaceutical preparation containing inhibitors of the sodium hydrogen exchange and a medicament for the treatment of cardiovascular diseases |
| 08/25/1999 | EP0937458A2 Pyrrolidine and piperidine derivatives |
| 08/25/1999 | EP0937146A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
| 08/25/1999 | EP0937085A1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same |
| 08/25/1999 | EP0937073A2 Selective factor xa inhibitors |
| 08/25/1999 | EP0937065A1 Constrained somatostatin agonists and antagonists |
| 08/25/1999 | EP0937047A1 1-arylphthalazine antagonists of excitatory amino acid receptors |
| 08/25/1999 | EP0937042A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 08/25/1999 | EP0937038A1 Vitamin d analogues |
| 08/25/1999 | EP0937036A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/25/1999 | EP0937035A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications |
| 08/25/1999 | EP0937030A1 3-amino-propoxyphenyl derivatives (i) |
| 08/25/1999 | EP0936930A1 Myocardial graft constructs |
| 08/25/1999 | EP0936910A2 Intracoronary stents containing quinazolinone derivatives |
| 08/25/1999 | EP0839036B1 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls |
| 08/25/1999 | EP0751934B1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 08/25/1999 | CN1226893A Selected derivatives of K-252a |
| 08/25/1999 | CN1226823A Pharmaceutical composition comprising coenzyme Q10 |
| 08/25/1999 | CN1226803A Diphenyl heterocycles as potassium channel modulators |
| 08/25/1999 | CN1226439A Composite medicinal injection for hemiparalysis |
| 08/24/1999 | US5942631 Inhibitors of cholesterol esterase |
| 08/24/1999 | US5942622 Novel compounds for treating illness resulting from abnormal stimulation of endothelial receptors; for example: 4-((6-chloro-1,3-benzodioxol-5-yl)methyl)-1-(cyclohexylmethyl) -3-(2-pyridinyl)-1h-pyrazole-5-carboxylate |
| 08/24/1999 | US5942524 Serotonin(5-ht-1) agonists |
| 08/24/1999 | US5942523 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools |
| 08/24/1999 | US5942522 1-benzyl-3-ethoxycarbonyl-4-dimethylaminoethoxy-6-methyl-2-(1h) -quinolinone; antiviral against dna containing viruses, such as herpes group viruses |
| 08/24/1999 | US5942517 Antagonist of alpha(1c) receptors; treatment of benign prostatic hyperplasia |
| 08/24/1999 | US5942516 Endothelin receptor antagonists |
| 08/24/1999 | US5942507 Furan nitrone compounds |
| 08/24/1999 | US5942497 Purine compound and catecholamine compound containing compositions and methods for administration |
| 08/24/1999 | US5942419 RsbW-1 encoding nucleic acids |
| 08/24/1999 | US5942405 Identifying compounds which inhibit complement receptors by mixing cells expressing surface complement receptors with a labeled compound capable of binding receptor and determining if compound inhibits interactions by signal generation |
| 08/24/1999 | US5942233 Herbal composition for stimulating blood circulation |
| 08/24/1999 | US5941868 Localized intravascular delivery of growth factors for promotion of angiogenesis |
| 08/24/1999 | CA2212548C Use of carbazole compounds for the treatment of congestive heart failure |
| 08/24/1999 | CA2141969C Cardio-protective agent |
| 08/20/1999 | CA2249653A1 Novel compounds |
| 08/19/1999 | WO1999041254A1 NOVEL TRIAZOLO(4,5-d)PYRIMIDINE COMPOUNDS |
| 08/19/1999 | WO1999041246A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 08/19/1999 | WO1999041240A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors |
| 08/19/1999 | WO1999040945A2 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery |
| 08/19/1999 | WO1999040914A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors |
| 08/19/1999 | WO1999040867A1 Treatment of brain edema using carbonic anhydrase enzyme inhibitor |
| 08/19/1999 | WO1999040788A1 Inotropic and diuretic effects of exendin and glp-1 |
| 08/19/1999 | WO1999030741A3 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases |
| 08/19/1999 | WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 08/19/1999 | WO1999029662A3 Urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof |
| 08/19/1999 | WO1999024451A3 Adenosine a1 receptor agonists |
| 08/19/1999 | WO1999024450A3 Adensine a1 receptor agonists |
| 08/19/1999 | WO1999024449A3 Adenosine a1 receptor agonists |
| 08/19/1999 | WO1999023996A3 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor |
| 08/19/1999 | DE19859526A1 Pharmaceutical composition, especially for gene transfer and therapy |
| 08/19/1999 | DE19806438A1 New pyrimidinyloxy-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiac insufficiency, restenosis, hypertension, kidney failure, asthma and prostate cancer |
| 08/19/1999 | DE19806348A1 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln 3,4-dihydroquinoline derivatives and their use in medicaments |
| 08/19/1999 | CA2320934A1 Treatment of brain edema using carbonic anhydrase inhibitor |
| 08/19/1999 | CA2320302A1 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery |
| 08/19/1999 | CA2319173A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 08/19/1999 | CA2319082A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors |
| 08/19/1999 | CA2316264A1 Novel triazolo(4,5-d)pyrimidine compounds |
| 08/18/1999 | EP0936221A1 Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient |
| 08/18/1999 | EP0936216A1 Novel acetamide derivatives and protease inhibitors |
| 08/18/1999 | EP0935962A1 Use of 5-(1,2-dithiolan-3-yl)valeric acid (alpha-lipoic acid) or its physiologically acceptable salts for treating lipid metabolism disorders |
| 08/18/1999 | EP0935651A2 THERAPY FOR $g(a)-GALACTOSIDASE A DEFICIENCY |
| 08/18/1999 | EP0935471A1 Mononuclear phagocytes in therapeutic drug delivery |
| 08/18/1999 | EP0935469A1 Use of growth hormone |
| 08/18/1999 | EP0935465A1 Novel substituted imidazole compounds |
| 08/18/1999 | EP0935415A1 Methods for delivering compounds into a cell |
| 08/18/1999 | EP0792292B1 Orphan receptor |
| 08/18/1999 | EP0789715A4 Complementarily bonded two- and three-dimensional supramolecular structures |
| 08/18/1999 | EP0620817B1 Piperazine derivatives as 5-ht receptors antagonists |
| 08/18/1999 | CN1226171A Type-2 chemokine binding proteins and methods of use thereof |
| 08/18/1999 | CN1226166A Formulation and method for treating congestive heart failure |
| 08/18/1999 | CN1225832A Use of plant mentha spicata for preparing pile-treating medicine |
| 08/18/1999 | CN1225831A Pile-diminishing capsule |
| 08/18/1999 | CN1044705C (1-phenyl-1-heterocyclyl) alkane derivatives and their preparation method and use |
| 08/17/1999 | US5939583 Antiarthritic agents; bone, cardiovascular, brain, nervous system disorders; antitumor and antimetastasis agents |
| 08/17/1999 | US5939543 Stable solid 2-octynyl adenosine and process for producing the same |
| 08/17/1999 | US5939525 Methods of treating inflammation and compositions therefor |
| 08/17/1999 | US5939462 NPY5 receptor antagonists and methods for using same |
| 08/17/1999 | US5939434 Tetrazolyl-substituted quinuclidines as substance P antagonists |
| 08/17/1999 | US5939432 Thiophenes useful for modulating the adenosine receptor |
| 08/17/1999 | US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies |
| 08/17/1999 | US5939405 Potassium channel modulators |
| 08/17/1999 | US5939398 Hypocholesterolemic agents |
| 08/17/1999 | US5939389 Use of C1-inactivation for therapy of certain diseases |
| 08/17/1999 | US5939284 Protein phosphatase 1 binding protein, R5 |
| 08/12/1999 | WO1999040198A2 Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
| 08/12/1999 | WO1999040197A2 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf |
| 08/12/1999 | WO1999040100A1 45 human secreted proteins |
| 08/12/1999 | WO1999040091A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 08/12/1999 | WO1999040088A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| 08/12/1999 | WO1999040085A1 Benzofuran-4-carboxamides and their therapeutic use |
| 08/12/1999 | WO1999040080A1 Hydroxamic and carboxylic acid derivatives |
| 08/12/1999 | WO1999040072A1 Five-membered, benzo-condensed heterocycles used as antithrombotic agents |
| 08/12/1999 | WO1999040064A1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
| 08/12/1999 | WO1999040061A2 Novel dihydroxyhexanoic acid derivatives |